Active Recombinant Cynomolgus CD3E&CD3D protein, His-tagged
Cat.No. : | CD3E&CD3D-593C |
Product Overview : | Recombinant Cynomolgus CD3E&CD3D protein(Q95LI5Gln22-Asp117)&Q95LI8(Phe22-Ala105)), fused with His tag, was expressed in HEK293. |
- Specification
- Gene Information
- Related Products
- Download
Source : | HEK293 |
Species : | Cynomolgus |
Tag : | His |
Form : | Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. |
Bio-activity : | Anti-Human CD3xBCMA(Teclistamab) captured on Protein A chip, can bind Recombinant Cynomolgus CD3E & CD3D/His Protein with a KD constant of 6.61E-09 M, determined in a SPR assay. |
Molecular Mass : | The protein has a calculated MW of 15/13kDa.The reducing (R) heterodimer protein migrates as 20-22 kDa and 17-20 kDa due to glycosylation |
Protein Length : | Gln22-Asp117&Phe22-Ala105 |
Endotoxin : | <1EU/mg |
Purity : | SDS-PAGE>90%,SEC>95% |
Storage : | Store at -20°C. |
Reconstitution : | sterile H49O |
Products Types
◆ Recombinant Protein | ||
CD3E-142H | Recombinant Human CD3E Protein, His and Fc-tagged | +Inquiry |
CD3E-141H | Recombinant Human CD3E Protein, His-tagged | +Inquiry |
CD3E-2193H | Active Recombinant Human CD3E Protein, His-Avi-tagged, Biotinylated | +Inquiry |
Cd3e-839M | Recombinant Mouse Cd3e Protein, MYC/DDK-tagged | +Inquiry |
CD3E-321H | Recombinant Human CD3E Protein, His-tagged | +Inquiry |
◆ Lysates | ||
CD3E-1602CCL | Recombinant Cynomolgus CD3E cell lysate | +Inquiry |
CD3E-1275HCL | Recombinant Human CD3E cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionYes, CD3E levels and T-cell function can be monitored to evaluate the response to cancer immunotherapies like checkpoint inhibitors.
There are currently no approved therapies that directly target CD3E, but it is a target for research in developing immunotherapies and cancer treatments.
There may be ongoing clinical trials using CD3E-targeted therapies in the context of cancer and autoimmune diseases. It's important to check clinical trial databases for specific studies.
Yes, monitoring CD3E levels in HIV-infected individuals can provide valuable information about the progression of the disease and the effectiveness of antiretroviral therapy.
CD3E can be used in research to study T-cell responses in allergic conditions, helping to better understand and diagnose allergies.
Customer Reviews (3)
Write a reviewManufacturers with the capacity for bulk production can offer CD3E protein in larger quantities, which is advantageous for researchers working on large-scale experiments or collaborations.
bulk production often leads to economies of scale, making the CD3E protein more cost-effective for research budgets.
Manufacturers can actively seek collaborations and partnerships with researchers to develop new applications or optimize methodologies using CD3E protein.
Ask a Question for All CD3E Products
Required fields are marked with *
My Review for All CD3E Products
Required fields are marked with *
Inquiry Basket